Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 265,602 | 304,696 | 413,083 | 242,624 | 280,720 |
| Marketable Securities | 915,726 | 1,021,778 | 1,078,257 | 911,794 | 915,789 |
| Other current assets | 21,598 | 16,643 | 16,643 | 17,476 | 81,584 |
| TOTAL | $1,202,926 | $1,343,117 | $1,507,983 | $1,171,894 | $1,278,093 |
| Non-Current Assets | |||||
| PPE Net | 17,163 | 17,177 | 15,824 | 13,736 | 12,243 |
| Investments And Advances | 2,635 | 3,141 | 8,218 | 11,253 | 8,947 |
| Other Non-Current Assets | 57,066 | 57,864 | 56,729 | 56,547 | 56,414 |
| TOTAL | $76,864 | $78,182 | $80,771 | $81,536 | $77,604 |
| Total Assets | $1,279,790 | $1,421,299 | $1,588,754 | $1,253,430 | $1,355,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,269 | 27,938 | 35,163 | 42,923 | 23,869 |
| Accrued Expenses | 94,878 | 95,633 | 108,495 | 79,156 | 91,997 |
| TOTAL | $119,147 | $123,571 | $143,658 | $122,079 | $180,866 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 65,000 |
| Other Non-Current Liabilities | 48,639 | 48,446 | 48,058 | 47,326 | 45,911 |
| TOTAL | $48,639 | $48,446 | $48,058 | $47,326 | $45,911 |
| Total Liabilities | $167,786 | $172,017 | $191,716 | $169,405 | $226,777 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,610 | 55,527 | 55,488 | 51,816 | 51,623 |
| Common Shares | 56 | 56 | 55 | 52 | 52 |
| Retained earnings | -2,076,853 | -1,900,408 | -1,712,022 | -1,512,402 | -1,432,348 |
| Other shareholders' equity | 3,357 | 4,266 | 9,068 | 9,595 | 9,601 |
| TOTAL | $1,112,004 | $1,249,282 | $1,397,038 | $1,084,025 | $1,128,920 |
| Total Liabilities And Equity | $1,279,790 | $1,421,299 | $1,588,754 | $1,253,430 | $1,355,697 |